Bionomics Profit Margin

The latest profit margin for BNOX is 2468.88% as of March 2026. That compares with 53.84% in the prior-year period — up 4485.8% year over year. That is above the Healthcare sector average of 14.34%. Investors often review this figure alongside Bionomics's historical trend and sector peers before judging valuation or financial health.

Over the past year, BNOX's profit margin moved from 53.84% to 2468.88% — a 4485.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bionomics's valuation or profitability profile.

Against Healthcare companies, BNOX currently prints 2468.88% for profit margin, while the sector average sits near 14.34%. That is roughly 17111.0% above the sector mean. Large gaps often invite a closer look at Bionomics's growth, margins, and balance sheet.

Profit Margin shows how effectively Bionomics converts resources into returns. At 2468.88%, BNOX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 53.84% in the prior-year period — up 4485.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BNOX's profit margin (2468.88%), review year-over-year change from 53.84%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.